Skip to main content

. 1982 Apr 17;284(6323):1160–1161. doi: 10.1136/bmj.284.6323.1160

Cyclophosphamide treatment of systemic lupus erythematosus: risk of bladder cancer exceeds benefit.

R W Elliott, D M Essenhigh, A R Morley

PMCID: PMC1496855 PMID: 6803878

1160

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Kinlen L. J., Sheil A. G., Peto J., Doll R. Collaborative United Kingdom-Australasian study of cancer in patients treated with immunosuppressive drugs. Br Med J. 1979 Dec 8;2(6203):1461–1466. doi: 10.1136/bmj.2.6203.1461. [DOI] [PMC free article] [PubMed] [Google Scholar]
Wall R. L., Clausen K. P. Carcinoma of the urinary bladder in patients receiving cyclophosphamide. N Engl J Med. 1975 Aug 7;293(6):271–273. doi: 10.1056/NEJM197508072930604. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES